Literature DB >> 18377831

Swing of the pendulum: optimizing functional outcomes in larynx cancer.

F Christopher Holsinger1.   

Abstract

For years, total laryngectomy was the only treatment option for patients with intermediate to advanced laryngeal cancer. Over the past two decades, great progress has been made in the management of this disease, with multimodality approaches aimed at laryngeal preservation reshaping the treatment landscape. In the era of chemoradiation, greater focus and attention are now directed toward functional laryngeal preservation--not simply "organ preservation." The continued development and integration of new treatment approaches, including organ preservation surgery (eg, transoral minimally invasive surgery of the head and neck, supracricoid partial laryngectomy), intensity-modulated radiotherapy, and targeted molecular therapies, offer the potential to improve clinical outcomes, function, and quality of life. Incorporation of these new approaches advances the concept of personalized medicine, with treatment strategies tailored to the circumstances and future of each patient.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18377831     DOI: 10.1007/s11912-008-0026-7

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  35 in total

1.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

Authors:  J P Pignon; J Bourhis; C Domenge; L Designé
Journal:  Lancet       Date:  2000-03-18       Impact factor: 79.321

Review 2.  Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls.

Authors:  William M Mendenhall; Robert J Amdur; Jatinder R Palta
Journal:  J Clin Oncol       Date:  2006-06-10       Impact factor: 44.544

3.  Cricohyoidoepiglottopexy for glottic carcinoma with fixation or impaired motion of the true vocal cord: 5-year oncologic results with 112 patients.

Authors:  D Chevalier; O Laccourreye; D Brasnu; H Laccourreye; J J Piquet
Journal:  Ann Otol Rhinol Laryngol       Date:  1997-05       Impact factor: 1.547

4.  Xerostomia following radiotherapy of the head and neck affects vocal function.

Authors:  Jong-Lyel Roh; Ah-Young Kim; Moon June Cho
Journal:  J Clin Oncol       Date:  2005-05-01       Impact factor: 44.544

5.  Local control after supracricoid partial laryngectomy for "advanced" endolaryngeal squamous cell carcinoma classified as T3.

Authors:  Xavier Dufour; Stéphane Hans; Erwan De Mones; Daniel Brasnu; Madeleine Ménard; Ollivier Laccourreye
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2004-09

6.  The addition of mood and anxiety domains to the University of Washington quality of life scale.

Authors:  Simon N Rogers; Suzanne Gwanne; Derek Lowe; Gerry Humphris; Beven Yueh; Ernest A Weymuller
Journal:  Head Neck       Date:  2002-06       Impact factor: 3.147

7.  Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer.

Authors:  K S Clifford Chao; Gokhan Ozyigit; Binh N Tran; Mustafa Cengiz; James F Dempsey; Daniel A Low
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-02-01       Impact factor: 7.038

8.  Transoral laser microsurgery for advanced laryngeal cancer.

Authors:  Michael L Hinni; John R Salassa; David G Grant; Bruce W Pearson; Richard E Hayden; Alexios Martin; Hans Christiansen; Bruce H Haughey; Brian Nussenbaum; Wolfgang Steiner
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2007-12

9.  Eating ability in head and neck cancer patients after treatment with chemoradiation: a 12-month follow-up study accounting for dropout.

Authors:  Alfred W Rademaker; Edward F Vonesh; Jeri A Logemann; Barbara Roa Pauloski; Dachao Liu; Cathy L Lazarus; Lisa A Newman; Annette Hamner May; Ellen MacCracken; Joy Gaziano; Linda Stachowiak
Journal:  Head Neck       Date:  2003-12       Impact factor: 3.147

10.  Swing of the surgical pendulum: a return to surgery for treatment of head and neck cancer in the 21st century?

Authors:  F Christopher Holsinger; Randal S Weber
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007       Impact factor: 7.038

View more
  11 in total

Review 1.  Current concepts of organ preservation in head and neck cancer.

Authors:  C-J Wang; R Knecht
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-11-25       Impact factor: 2.503

2.  [The value of supracricoid partial laryngectomy in moderately advanced laryngeal cancer (T3-T4a)].

Authors:  U Schroeder; B Wollenberg; K L Bruchhage
Journal:  HNO       Date:  2015-11       Impact factor: 1.284

3.  [Adjuvants in operative laryngology].

Authors:  C Sittel
Journal:  HNO       Date:  2008-12       Impact factor: 1.284

Review 4.  Targeted therapy in head and neck cancer.

Authors:  S K Kundu; M Nestor
Journal:  Tumour Biol       Date:  2012-02-29

Review 5.  Conservative treatment for advanced T3-T4 laryngeal cancer: meta-analysis of key oncological outcomes.

Authors:  Giuditta Mannelli; Maria Silvia Lazio; Paolo Luparello; Oreste Gallo
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-11-08       Impact factor: 2.503

Review 6.  Current trends in initial management of laryngeal cancer: the declining use of open surgery.

Authors:  Carl E Silver; Jonathan J Beitler; Ashok R Shaha; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-07-14       Impact factor: 2.503

Review 7.  Minimally Invasive Procedures for Laryngeal Carcinoma: Transoral Endoscopic Laser and Transoral Robotic Surgery.

Authors:  Özgül Topal
Journal:  Turk Arch Otorhinolaryngol       Date:  2017-03-01

8.  Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer.

Authors:  F Christopher Holsinger; Merrill S Kies; Eduardo M Diaz; Ann M Gillenwater; Jan S Lewin; Lawrence E Ginsberg; Bonnie S Glisson; Adam S Garden; Nebil Ark; Heather Y Lin; J Jack Lee; Adel K El-Naggar; Waun Ki Hong; Dong M Shin; Fadlo R Khuri
Journal:  J Clin Oncol       Date:  2009-03-16       Impact factor: 44.544

9.  Functional and oncological outcomes of primary versus salvage transoral laser microsurgery for supraglottic carcinoma.

Authors:  Katherine A Hutcheson; Kitti Jantharapattana; Denise A Barringer; Jan S Lewin; F Christopher Holsinger
Journal:  Ann Otol Rhinol Laryngol       Date:  2012-10       Impact factor: 1.547

10.  Oxymatrine downregulates HPV16E7 expression and inhibits cell proliferation in laryngeal squamous cell carcinoma Hep-2 cells in vitro.

Authors:  Xin-Jiang Ying; Bin Jin; Xin-Wei Chen; Jin Xie; Hong-Ming Xu; Pin Dong
Journal:  Biomed Res Int       Date:  2015-02-24       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.